• Fri. Sep 25th, 2020

Dimancherouge

Technology

clinical

  • Home
  • Large Randomized Clinical Trial Validates 2Morrow’s Digital Health Approach to Behavior-modification and Proves that Apps can Help Smokers Quit

Large Randomized Clinical Trial Validates 2Morrow’s Digital Health Approach to Behavior-modification and Proves that Apps can Help Smokers Quit

The MarketWatch News Department was not involved in the creation of this content. KIRKLAND, Wash., Sept. 23, 2020 /PRNewswire via COMTEX/ — KIRKLAND, Wash., Sept. 23, 2020 /PRNewswire/ — 2Morrow, Inc.’s…

PolyU launches the first dedicated interdisciplinary master programme in medical physics to nurture future clinical and academic talents in the field

HONG KONG, Sept. 23, 2020 /PRNewswire/ — As medical technology advances, breakthroughs in diagnosing and treating various critical illnesses are achieved, and as the design of patient treatment plans becomes more…

Clinical Evaluation of Individualized and Navigated Microsecond Pulsing Laser for Acute Central Serous Chorioretinopathy

Introduction Central serous chorioretinopathy (CSC) is a pathology of the central zone of the retina occurring predominantly in young/middle-aged males. It is characterized by an idiopathic serous detachment of the…

Signant Health Launches New eCOA Master Class Web Series Taught by Clinical Research Science and Technology Experts

PHILADELPHIA, Sept. 21, 2020 /PRNewswire/ — Signant Health today introduced “eCOA Explained,” a new Master Class web series designed to elevate the understanding and skills of clinical operations professionals interested in…

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market: COVID-19 Business Continuity Plan | Evolving Opportunities With AMETEK Inc. and Blacktrace Holdings Ltd. | Technavio

LONDON–(BUSINESS WIRE)–The global fluidics for preclinical, life science research, and clinical applications market is expected to grow by USD 1.38 billion as per Technavio. This marks a significant market slow…

Sojournix Announces Publication of Results from SJX-653 Proof-of-Mechanism Study in The Journal of Clinical Endocrinology & Metabolism

– Novel, Potent, Selective NK3 Antagonist in Phase 2 Clinical Development for Menopausal Hot Flashes – – Statistically Significant Effect on Pharmacodynamic Markers of NK3 Receptor Antagonism and Once-Daily (QD)…

The Playbook guides the safe and effective use of digital clinical measures across clinical research, patient care and public health

The Playbook guides the safe and effective use of digital clinical measures across clinical research, patient care and public health PR Newswire BOSTON, Sept. 17, 2020 This open science effort…

Smart Pills Drug Delivery Market Global Research and Clinical Survey Report 2020 to 2025

The MarketWatch News Department was not involved in the creation of this content. Sep 16, 2020 (Market Insight Reports) — The report elaborates the complete details covering product definition, product…

Heritable genome editing technology is not yet ready for clinical use

Credit: CC0 Public Domain Gene editing technologies developed in the past decade have proven to be extraordinarily powerful and hold the potential to someday cure or prevent a range of…